Answers are grounded in this paper and cite their sources.
Lung cancer treatmentLate diagnosis and inefficient treatment lead to poor prognosis for most of the lung cancer patients.Improvement of the survival rate and quality of life requires establishment of efficient treatments through gaining comprehensive knowledge of the prevalence, incidence and clinical importance of known genetic alterations and discovery of novel alterations and targeted and immunotherapeutic agents.Therefore, comprehensive genomic analyses and functional preclinical validation are essential for expanding the potentially actionable genomic aberrations and discovering their therapeutic value.
No takes yet. Share an insight, caveat, or question.
Ljoncheva et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: